Stock Gainers
-
WD-40 Co. (WDFC, +2.08%): The company’s shares rallied 4% in premarket trade, surpassing Wall Street estimates for the quarter.
-
Better Therapeutics Inc. (BTTX, -19.64%): The microcap company witnessed a significant surge of 52% ahead of a conference call. This surge followed the Food and Drug Administration’s approval of its smartphone-based behavioral therapy for individuals with Type 2 diabetes.
Stock Decliners
-
Iovance Biotherapeutics (IOVA, +21.41%): The stock slumped 12% as the company revealed its plan to sell $150 million in stock.
-
Viridian Therapeutics Inc. (VRDN, +5.06%): The biotech drug maker’s shares fell more than 15% after hours Monday. This decline followed the announcement of changes in the study design for their chronic thyroid eye disease therapy.
-
ADT Inc. (ADT, +2.26%): The home-security and alarm-monitoring company’s stock dropped more than 4% in the extended session Monday. ADT stated in a filing that it will have to restate some financial results due to mistakes in dealing with quarterly impairment losses.
